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ABSTRACT
Objective: To evaluate reproductive health of males with idiopathic inflammatory myopathies (IIM), and comparing 
them with a control group. Methods: Demographic data, urologic evaluation (including pubertal parameters and sexu-
al/erectile function), testicular ultrasound, hormone profile, semen analysis, clinical features, and treatment of 25 IIM 
patients were evaluated. The control group was composed of 25 healthy males. Results: Median age of IIM patients 
was similar to that of the control group (24 versus 27 years, P = 0.566). The frequency of sexual activity, number of 
partners with spontaneous pregnancies after the onset of the disease, and use of condom were significantly lower in 
IIM patients than in the control group (60% versus 96%, P = 0.004; 16% versus 60%, P = 0.0031; 40% versus 76%, P = 
0.021, respectively). Moreover, the frequency of testicular atrophy (28% versus 4%, P = 0.049), elevated levels of FSH 
and/or LH (25% versus 0%, P = 0.05), and sperm abnormalities (40% versus 0%, P = 0.0006) were statistically higher 
in IIM patients than in the control group. Median age of onset of IIM and current age were significantly higher in IIM 
patients with sexual/erectile dysfunction than in patients without this dysfunction (41 versus 12.5 years, P = 0.014; 46 
versus 21 years, P = 0.027, respectively). On the other hand, differences in the age of spermarche, parameters of gona-
dal function, disease activity, muscle enzymes, and treatment were not observed between IIM patients with or without 
sexual/erectile dysfunction. Conclusion: This is the first study to identify changes in reproductive health and gonadal 
dysfunction in male IIM patients. Rheumatologists should discuss sexual problems with their patients, counseling them 
on contraceptive methods.
Keywords: reproductive health, sexual function, sperm, hormone, idiopathic inflammatory myopathy, male.
INTRODUCTION
Idiopathic inflammatory myopathies (IIM), such as 
dermatomyositis (DM), juvenile dermatomyositis (JDM), 
and polymyositis (PM), are systemic autoimmune disorders 
characterized by chronic muscular imflammation and 
progressive muscular weakness. Clinical and electromyographic 
characteristics are similar among the different disorders, and 
muscle biopsy is considered the “gold standard” for the 
differential diagnosis.1,2 The annual incidence of IIM ranges 
from 0.5 to 8.4 cases per one million people, with higher 
frequency in two age groups (10 to 15 years and 45 to 64 
years), affecting more females than males.1,2
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Since 1960, the survival and prognosis of IIM patients have 
improved significantly due to the introduction of corticosteroids 
followed by immunosuppresants.2 Those aspects reinforce 
the importance of studies on quality of life, including the 
assessment of testicular function and reproductive health,3-6 
such as pubertal landmarks, sexual function, and fertility.3
Recently, studying parameters of gonadal function in 
10 adult males with DM and a control group composed of 
10 matched males, without assessing sexual function, we 
identified a higher frequency of gonadal dysfunction associated 
with disease activity in those patients when compared to 
the control group.6 In systemic lupus erythematosus (SLE), 
those changes were associated with the use of intravenous 
cyclophosphamide.7-10
Changes in the reproductive health of male adolescents 
with JDM have also been reported in the literature4. However, 
the literature lacks studies evaluating sexual and/or erectile 
function in IIM patients using adequately the word infertility, 
according to the definition of the World Health Organization 
(WHO). The World Health Organization emphasizes the need 
to evaluate the couple, and it defines infertility as the absence 
of conception after a consecutive period of 12 months of sexual 
activity without contraceptive methods.11
Thus, the objective of the present study was to evaluate 
gonadal function and reproductive health of males with IIM, 
comparing them with a control group of healthy males, and 
to establish possible associations among demographic data, 
parameters of gonadal function and reproductive health, disease 
activity, muscle enzymes, and treatment in patients with and 
without sexual and/or erectile dysfunction.
PATIENTS AND METHODS
Patients with IIM and in the control group
Forty consecutive male patients between the ages of 15 and 54 
years were selected for this study between January 2006 and 
January 2008. This represents the entire patient population on 
regular follow-up at four Rheumatology Services in the city 
of São Paulo: Pediatric Rheumatology Unit of the Instituto da 
Criança (ICr) of Hospital das Clínicas (HC) of the Medical 
School of Universidade de São Paulo (FMUSP), Myopathies 
Outpatient Clinic of the Rheumatology Department of HC/
FMUSP, Pediatric Rheumatology Department of Universidade 
Federal de São Paulo, and Pediatric Rheumatology Department 
of Santa Casa de São Paulo. All patients fulfilled Borhan and 
Peter criteria for the diagnosis of IIM.12 Patients did not have 
malignancies associated with IIM.
Exclusion criteria were as follows: hydrocele, hypospadia, 
cryptorchidism, testicular mumps infection, testicular cancer, 
orchitis, testicular vasculitis, ureteral dysfunction, history of 
scrotal or inguinal surgery, diabetes mellitus, current history of 
alcohol abuse or smoking, and refusal to collect semen samples 
or incomplete evaluation. Fifteen patients were excluded: eight 
for refusing to participate in the study, five for incomplete exam 
evaluation, one due to orchidopexia due to cryptorchidism, and 
one due to left testicular ectopy. The remaining 25 patients 
were evaluated (13 JDM, 10 DM, and two PM) and compared 
to a control group of 25 healthy individuals: 10 adolescents 
followed-up at the Adolescent Unit of ICr-FMUSP, and 15 
adults followed-up at the Urology Division of the Vasectomy 
Outpatient Clinic of FMUSP. Socio-economic classes were 
evaluated according to the classification of the Brazilian 
Association of Market Research Institutes.13 The study was 
approved by the Ethics on Research Committee of HC-FMUSP, 
and patients or, when applicable, legal guardians signed an 
informed consent.
Reproductive Health Evaluation
History and urologic exam
Evaluations included: demographic data (age at the onset of 
the disease, duration of IIM, and current age), body mass index 
(BMI corresponding to body weight in kilograms divided by 
the square of the height in meters), age of the first ejaculation 
(spermarche by masturbation, nocturnal ejaculation, or sexual 
activity), age of the onset of sexual activity, frequency and 
number of sexual activities in the previous month, pregnant 
partners, history of sexual or ejaculatory dysfunction [reduced 
libido, erectile dysfunction, premature ejaculation, absence of 
orgasm (anorgasmia), and/or complains with one’s sex life].11,14 
Infertility was defined as the absence of conception after a 
period of 12 consecutive months of sexual activity without 
the use of contraceptive methods.
The study subjects underwent a systematic clinical 
exam of the genitalia by the same urologist of the Human 
Reproduction Center of HC-FMUSP, including evaluation 
of the testicles, epididymides, vas deferens, scrotum, and 
penis.11 Sexual characteristics were evaluated according to 
the pubertal criteria proposed by Tanner, i.e., distribution of 
pubic hair and characteristics of the genitalia.15 Testicular 
volume was measured with a Prader orchidometer, which 
consists of 12 numbered beads from 1 to 25 mL (1 to 6, 8, 
10, 12, 15, 20, and 25 mL).16 In post-pubertal adolescents 
and adult males, testicular atrophy was defined as a testicular 
volume < 12 mL.17
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Evaluation of Gonadal Function
Testicular Doppler US scan
All patients underwent testicular US scan performed by the 
same ultrasonographist from the Radiology Department of 
HC-FMUSP, a specialist in testicular US scan, using a 14-
MHz scanner (Logic 9-GE-Milwauke, Wisconsin, USA), who 
was blinded regarding the analysis of reproductive health and 
other parameters of gonadal function. Testicular US scan has 
better accuracy and precision when measuring the size of the 
testicles than Prader orchidometry.3 Testicles were measured 
on the axial and longitudinal planes by obtaining at least two 
measurements of the width, length, and thickness. The higher 
measurement of each dimension was recorded and used to 
calculate testicular volume according to the formula for the 
volume of ellipsoids (width x length x thickness x 0.52). In 
post-pubertal adolescents and adult males, testicular atrophy 
on US scan was defined as a testicular volume < 7 mL.18
Hormonal profile and primary hypogonadism
Hormone levels were measured at the beginning of the study 
at the Medical Investigation Laboratory (LIM 36, from the 
Portuguese) of the Pediatrics Department of FMUSP. Abnormal 
results were repeated for confirmation. Follicle-stimulating 
hormone (FSH), luteinizing hormone (LH), and total 
testosterone levels were measured by immunofluorescence 
using DELPHIA® time-resolved fluoroimmunoassay kits 
(WALLAC Ou, Turku, Finland). Inter- and intra-analysis 
coefficient of variation were 3.5% and 2.1%, respectively). 
Normal levels were as follows: FSH (1 – 10.5 IU/l), LH (1 – 
8.4 IU/l), and total testosterone (271 – 965 ng/dL). Primary 
hypogonadism was defined by elevated serum levels of 
hypophyseal gonadotropins (FSH and/or LH) and decreased 
levels of total testosterone.19
Changes in spermatozoids
Analysis of spermatozoids, following the directives of the 
WHO,11,20 were performed by two experienced biomedical 
technicians from the Human Reproduction Center of HC-
FMUSP, who were blinded regarding the other parameters of 
reproductive health and gonadal function. All study subjects 
collected two semen samples, by masturbating in a collection 
room after 48 to 72 hours of sexual abstinence, up to one 
month after inclusion in the study. After collection, samples 
were processed within one hour of liquefaction and underwent 
both manual count and computer-assisted spermatozoid count 
under 400 x magnification using the HTM-2030 (Hamilton 
Thorne Research, Beverly, Massachusetts, USA). Each device 
was scanned to estimate the number of spermatozoids per 
1mL field to obtain the approximate spermatozoid count in 
millions per milliliter of semen. Spermatozoid mortality was 
determined by the systematic analysis at least five microscopic 
fields to classify 200 spermatozoids. Their morphology 
included the evaluation of the head, neck, midpiece, and 
tail.11 Oligozoospermia was defined by a sperm concentration 
< 200 million/mL, astenozoospermia when the motility of 
spermatozoids was < 50%, teratozoospermia when normal 
spermatozoid morphology was < 15%, according to the WHO, 
and oligoastenoteratozoospermia was characterized by changes 
in all three parameters.11 Spermatozoid morphology was also 
evaluated according to Kruger’s strict criteria, in which normal 
morphology < 14% is associated with subfertility.21
Anti-spermatozoid antibodies
The presence of anti-spermatozoid antibodies was investigated 
in the first semen sample at the Human Reproduction Center of 
HC-FMUSP. The Immunobead test uses reagents containing 
rabbit immunoglobulins against anti-human spermatozoid 
antibodies (IgA, IgG, and IgM) (Irvine Scientific, Santa Ana, 
California, USA). Direct testing with tagged antibodies can 
detect antibodies bound to the surface of the spermatozoid 
(head, midpiece, and/or tail). At least 50% of mobile 
spermatozoids should be coated with tagged antibodies before 
the test is considered clinically significant.20 Quality control 
followed the recommendations of the manufacturer (Irvine 
Scientific, Santa Ana, California, USA).
Evaluation of IIM Scores, Muscle 
Enzymes, and Treatment
The visual analogue scale (VAS)22, ranging from 0 cm 
(inactive disease) to 10 cm (highest activity) was used for 
the global disease evaluation by the physician and patient at 
the time all parameters of reproductive health and gonadal 
function were assessed, and the following muscle enzymes 
were measured: creatino kinase (CK), lactate dehydrogenase 
(LDH), aldolase, alanine aminotransferase (ALT), and 
aspartate aminotransferase (AST). Treatment with prednisone, 
cyclophosphamide, azathioprine, and methotrexate was also 
evaluated.
Statistical Analysis
Results are presented as medians (variation), for continuous 
parameters, and numbers (%), for categorical parameters. 
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Results were compared by the t test or Mann-Whitney test, 
for continuous parameters, to determine the differences 
between IIM patients and the control group and between two 
groups of IIM patients: with and without sexual and/or erectile 
dysfunction. Fisher exact test was used to analyze categorical 
parameters. Values of P ≤ 0.05 were considered statistically 
significant.
RESULTS
Demographic data, body mass index, 
reproductive health, and gonadal function in 
males with IIM and in the control group
Current age and BMI were similar in IIM patients and the 
control group (24 versus 27 years, P = 0.566; 23 versus 21 kg/
m2, P = 0.1459, respectively). All study subjects had complete 
sexual development according to Tanner criteria, with adult 
pubic hair down to the medial aspect of the thighs (P5), and size 
and shape of adult genitalia (G5).15 Age of spermarche was not 
statistically different in both groups (13 versus 12 years, P = 
0.093). Mulattoes represented 100% of IIM patients and 96% of 
the control group (P = 1.0). The frequency of social-economic 
classes B and C was similar in both groups (80% versus 80%, 
P = 1.0). The first ejaculation noticed on masturbation was also 
similar in both groups (72% versus 60%, P = 0.551). The use 
of condoms was statistically lower among IIM patients than 
in the control group (40% versus 76%, P = 0.021).
As for parameters of reproductive health, sexual activity in 
the previous month was reported by 60% of IIM patients and 
96% of the control group, which was statistically significant (P 
= 0.004). Besides, the percentage of partners with spontaneous 
pregnancies after the onset of the disease was statistically lower 
in IIM patients when compared to the control group (16% versus 
60%, P = 0.0031). Median duration of the disease of the four 
patients whose partners had spontaneous pregnancies was seven 
years (1-10).
The age of the first sexual relationship, number of sexual 
activities in the previous month, presence of sexual/erectile 
dysfunction (reduced libido, erectile dysfunction, premature 
ejaculation, and/or anorgasmia) and dissatisfaction with one’s 
sex life of IIM patients and the control group was not statistically 
significant (P > 0.05, Table 1).
A relevant aspect of the presence study was the presence of 
infertility in only one 38-year old IIM patient and in none of the 
individuals in the control group (P = 1.0). The wife of this IIM 
patient was evaluated at the Human Reproductive Center of HC-
FMUSP; she had anovulatory menstrual cycles, without history 
of abortion, and all exams recommended for the evaluation of 
the female of an infertile couple were normal: pelvic US scan 
and hormones (thyroid, FSH, LH, estradiol, and prolactin). This 
patient had active disease (physician VAS 3, and patient VAS 
4), he had not been treated with cyclophosphamide, and he 
presented teratozoospermia. He had erectile dysfunction, being 
instructed to use 25 mg of sildenafil citrate 30 minutes before 
sex, which normalized the erection. He has been followed-up 
at the Human Reproductive Center of HC-FMUSP, but his wife 
has not become pregnant.
As for gonadal function, 40% of IIM patients had 
spermatozoidal changes [azoospermia (absence of spermatozoids) 
or teratozoospermia (abnormal morphology) associated with 
oligozoospermia (low concentration of spermatozoids), and/
or astenozoospermia (decreased mobility)] while they were not 
present in the control group (P = 0.0006). Testicular atrophy, 
evaluated by Prader orchidometry and increased levels of 
hypophyseal gonadotropins (FSH and/or LH), were more 
common in IIM patients than in the control group (28% versus 
4%, P = 0.049, and 25% versus 0%, P = 0.05, respectively). 
However, the incidence of other parameters of gonadal function, 
i.e., testicular atrophy on the US scan, primary hypogonadism, 
reduction in total testosterone levels, and presence of anti-
spermatozoid antibodies were not significantly different between 
both groups (P > 0.05, Table 1).
Parameters of reproductive health and 
gonadal function in IIM patients with and 
without sexual and/or erectile dysfunction
Three IIM patients (12%) had sexual/erectile dysfunction, 
while 22 patients (88%) had normal function. One IIM 
patient with erectile dysfunction and infertility was described 
previously. The other two patients are described below:
Patient 1 – 46 years old male with the diagnosis of DM for 
three years (criteria of Bohan & Peter).12 His first ejaculation was 
at 12 years of age, and he started his sexual activities at 17 years 
of age, but he did not report any sexual activities in the previous 
months. He complained of premature ejaculation without changes 
in libido, erection, and orgasm. He did not use condoms, and 
he was dissatisfied with his sex life. When he was 41 years old, 
his partner had a spontaneous pregnancy. He had left testicular 
atrophy [Prader orchidometry and testicular US scan (10 mL and 
3.4 mL, respectively)]. The serum levels of hormones were as 
follows: FSH 22.7 IU/l (1-10.5), LH 7.7 IU/l (1-8.4), and total 
testosterone 296 ng/dL (271-965). Both semen samples showed 
terato-oligozoospermia, and anti-spermatozoid antibodies were 
negative. This patient had active disease with physician VAS of 
Reproductive health in men with idiopathic inflammatory myopathy
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5 and patient VAS of 4. The following muscle enzymes were 
evaluated: CK 420 IU/l (39-308), ALT 28 IU/l (24-49), AST 14 
IU/l (10-36), LDH 485 IU/l (240-480), and aldolase 5 IU/l (< 7.6). 
Treatment for disease control included prednisone (current dose 
of 15 mg/day and cumulative dose of 5 grams) and azathioprine 
(current dose 150 mg/day and cumulative dose of 17 grams).
Patient 2 – 38 years old male with the diagnosis of DM for 
one year (criteria of Bohan and Peter).12 The first ejaculation 
was at 16 years of age, and first sexual activity at 17 years of 
age, without sexual activity in the previous month. He reported 
decreased libido and anorgasmia, without erectile and ejaculation 
difficulties. He did not use condoms and he was dissatisfied with 
his sex life. He did not report pregnancy. He had normal right 
and left testicular volumes [Prader orchidometry (25/25 mL) 
and US scan (13/15.7 mL)]. Hormone levels were as follows: 
FSH 3.9 IU/l, LH 1.2 IU/l, and total testosterone 231 ng/dL. 
Semen samples showed teratozoospermia, and anti-spermatozoid 
antibodies were negative. At the time of the evaluation of 
reproductive health, he had active cutaneous disease (physician 
VAS 4 and patient VAS 3). Muscle enzymes were normal: CK 
68 IU/l, ALT 24 IU/l, AST 19 IU/l, LDH 454 IU/l, and aldolase 
4 IU/l. Treatment for DM included prednisone (current dose 
15 mg/day and cumulative dose 4.5 grams), and azathioprine 
(cumulative dose 15 grams).
DISCUSSION
The present multicenter study evaluated simultaneously 
parameters of reproductive health and testicular function 
in patients with inflammatory myopathies, demonstrating 
a reduction in sexual activity and higher frequency of 
gonadal dysfunction in males with IIM when compared to 
the control group.
Sexual function refers to the capacity to complete the 
sexual cycle, which includes interest, desire (libido), erection, 
ejaculation, orgasm, and satisfaction.23 In the present study, all 
those characteristics of sexual function were evaluated through 
the clinical history, as suggested by the WHO for evaluation of 
male infertility,11 without the use of a generic or specific tool of 
sexual function and/or depression. Dysfunction and reduction 
of the sexual activity, such as observed in IIM patients in this 
study, have been described in male populations with chronic 
rheumatic diseases, especially rheumatoid arthritis,24 ankylosing 
spondylitis,25 and SLE.26,27 On the other hand, studies evaluating 
the sexual function of IIM patients are rare, except for reports 
of pregnancy in females with those disorders.28-30 In the present 
study, 12% of the population of patients with myopathy 
had sexual dysfunction, with a predominance in middle age 
Table 1. Demographic data, body mass index, 
parameters of reproductive health, and gonadal 
function in males with idiopathic inflammatory 





(n = 25) P
Demographic data and BMI
Current age, years 24 (15-54) 27 (15-55) 0.566
BMI, kg/m2 23 (15-38) 21 (18-27) 0.149
Parameters of reproductive health
Age of spermarche, years 13 (11-18) 12 (11-15) 0.093
Spermarche due to 
masturbation 18 (72) 15 (60) 0.551
Tanner pubertal stage P5G5 25 (100) 25 (100) 1.0
Age of onset of sexual 
activity, years 15.7 (13-21) 16 (12-24) 0.944
Sexual activity in the 
previous month 15 (60) 24 (96) 0.004
Number of sexual 
relationships in the 
previous month
4 (0-28) 8 (0-16) 0.139
Partners with spontaneous 
pregnancies after 
the onset of IIM
4 (16) 15 (60) 0.0031
Sexual and/or erectile 
dysfunction 3 (12) 0 (0) 0.235
Decreased libido 1 (4) 0 (0) 1.0
Erectile dysfunction 1 (4) 0 (0) 1.0
Premature ejaculation 2 (8) 0 (0) 0.49
Anorgasmia 2 (8) 0 (0) 0.49
Dissatisfaction with 
one’s sex life 3 (12) 0 (0) 0.235
Use of condoms 10 (40) 19 (76) 0.021
Infertility 1 (4) 0 (0) 1.0
Gonadal function
Testicular atrophy according 
to Prader (R and/or L) 7 (28) 1 (4) 0.049
Testicular atrophy according 
to the US scan (R and/or L) 4 (16) 2 (8) 0.667
Primary hypogonadism 2 (8) 0 (0) 0.49
Total testosterone < 271 ng/dL 5 (25) 1 (4) 0.189
FSH >10.5 UI/L and/
or LH > 8.4 UI/L 5 (25) 0 (0) 0.05
Spermatozoidal changes* 10 (40) 0 (0) 0.0006
Anti-spermatozoid 
antibodies > 50% 0 (0) 0 (0) 1.0
Results expressed in numbers (%) or median (variation); P = pubic hair; G = genitalia; R = right;  
L = left; US scan = ultrasound; FSH = follicle-stimulating hormone; LH = luteinizing hormone;  
*patients with azoospermia (absence of spermatozoids) or teratozoospermia (abnormal 
spermatozoid morphology) associated with oligozoospermia (low spermatozoid 
concentration) and/or astenozoospermia (low spermatozoid motility).
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men and those whose disease started later in life. In fact, the 
incidence of global or specific (such as erectile dysfunction, 
premature ejaculation, anorgasmia, and sexual dissatisfaction) 
sexual dysfunction increases progressively with age.31 Sexual 
dysfunction could also be secondary to disease activity, myalgia, 
weakness, or muscular contracture, hindering sex, which was 
not observed in our patients.
Besides, only 40% of male patients with IIM used 
condoms during routine sexual relationships. Contraceptive 
guidelines involve the concept of double protection, i.e., 
protection against pregnancy and sexually transmitted diseases 
(including acquired immunodeficiency syndrome and human 
papillomavirus). Therefore, the use of condoms in all sexual 
relationships should be emphasized when orienting IIM patients 
regarding contraception.13,29 As for females, unprotected sex 
has increased the incidence of pregnancies, as demonstrated in 
our patients with JDM29 and by a recent multicenter Brazilian 
study on juvenile SLE involving 12 Pediatric Rheumatology 
Services in four states.32
It is interesting that both IIM patients and individuals in the 
control group started their sexual activity early in life (median 
15.7 years versus 16 years). This data was similar in two other 
studies by our group with women with chronic diseases, in 
which adolescents with SLE and the control group started sexual 
activities at a similar age (mean of 15.3 years), and the same was 
observed in adolescents with epilepsy versus a control group of 
matched healthy individuals (median 15 years).34
Similarly to menarche in females, spermarche represents 
an important pubertal landmark in the reproductive capacity 
of males.8 The age of the first ejaculation was not delayed in 
patients with inflammatory myopathies when compared to the 
control group. This finding was different from that of female 
patients with SLE whose menarche was delayed one year when 
compared to a group of healthy Brazilian adolescents.33,35
On the evaluation of male gonadal function, the reduction 
in testicular volume, according to Prader orchidometry, 
and spermatozoidal changes suggest severe aggression to 
seminiferous tubules in IIM patients. Besides, the levels of 
hypophyseal gonadotropins were higher in those patients. 
In fact, FSH is a marker of the function of the seminiferous 
epithelium9-11 and elevated levels suggest testicular lesion, 
according to what was observed previously by our group in male 
patients with SLE, reinforcing the need for cryopreservation 
of the semen, even without prior use of immunosuppresants, 
such as cyclophosphamide.9,10 It is also relevant that, despite 
the testicular dysfunction observed in our study, most patients 
still had satisfactory sexual function despite the reduced 
frequency of pregnancy in their partners after the onset of 
the disease. Another study that evaluated gonadal function 
based on dysfunction of Sertoli cells will be undertaken. This 
dysfunction will be evaluated through the hormone inhibin B, 
produced exclusively by the testicles.
To conclude, reproductive health and gonadal function are 
compromised in men with IIM. Patient care should include 
a discussion on sexuality and contraception, prevention of 
sexually transmissible diseases, teratogenicity of some drugs 
used in the treatment, as well as awareness of the risks of the 
disease and medication represent to fertility.
ACKNOWLEDGEMENTS
The authors would like to thank Professor Thelma Suely Okay, 
for the determination of hormone levels, and Dr. Ulysses Dória-
Filho, for his help with the statistical analysis.
REFERÊNCIAS
REFEREnCES
1. Sallum AM, Marie SK, Wakamatsu A et al. Difference in adhesion 
molecule expression (ICAM-1 and VCAM-1) in juvenile and 
adult dermatomyositis, polymyositis and inclusion body myositis. 
Autoimmun Rev 2006; 5:93-100.
2. Feldman BM, Rider LG, Reed AM, Pachman LM. Juvenile 
dermatomyositis and other idiopathic inflammatory myopathies of 
childhood. Lancet 2008; 371:2201-12.
3. Silva CA, Moraes AJ. Avaliação da função gonadal em adolescentes e 
jovens com doenças reumáticas. Rev Paulista Reumatol 2008; 7:6-9.
4. Moraes AJ, Pereira RM, Cocuzza M, Casemiro R, Saito O, Silva CA. 
Minor sperm abnormalities in young male post-pubertal patients with 
juvenile dermatomyositis. Braz J Med Biol Res 2008; 41:1054-8.
5. Sallum AM, Garcia AJ, Saito OC, Silva CA. Scrotum and testicular 
calcinosis in juvenile dermatomyositis (JDM). Report of two cases. 
Clin Exp Rheumatol 2009 (in press).
6. Moraes AJ, Bonfá E, Borges CT, Sato O, Silva CA. Global gonad 
evaluation in male idiopathic inflammatory myopathy. Clin Exp 
Rheumatol 2009 (submitted).
7. Silva CA, Hallak J, Pasqualotto FF et al. Gonadal function in 
adolescents and young men with systemic lupus erythematosus. J 
Rheumatol 2002; 29:2000-5.
8. Silva CA, Brunner HI. Gonadal functioning and preservation of 
reproductive fitness with juvenile systemic lupus erythematosus. 
Lupus 2007; 16:593-9.
9. Soares PM, Borba EF, Bonfa E et al. Gonad evaluation in male 
systemic lupus erythematosus. Arthritis Rheum 2007; 56:2352-61.
10. Suehiro RM, Borba EF, Bonfa E et al. Testicular Sertoli cell function 
in male systemic lupus erythematosus. Rheumatology (Oxford) 2008; 
47:1692-7.
11. Rowe PJ, Comhaire FH, Hargreave TB, Mahmoud AM. World Health 
Organization (WHO) for the standardized investigation, diagnosis 
and management of the infertile men. 1 ed. Cambridge, Cambridge 
University Press, 2000, pp. 1-86.
Reproductive health in men with idiopathic inflammatory myopathy
689Bras J Rheumatol 2009;49(6):677-89
12. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two 
parts). N Engl J Med 1975; 292:344-7.
13. Almeida PM, Wickerrhauser H. Critério de classe econômica da 
Associação Brasileira de Anunciantes (ABA) e Associação Brasileira 
dos Institutos de Pesquisa de Mercado (ABIPEME), 1991, pp. 1-29.
14. Silva CA, Leal MM, Leone C et al. Aspectos da sexualidade e 
gravidez de adolescentes e adultos jovens com lúpus eritematoso 
sistêmico (LES). Rev Bras Reumatol 2001; 41:213-9.
15. Tanner JM. Growth at adolescence. 2 ed. Oxford: Blackwell Scientific 
Publications, 1962.
16. Prader A. Testicular size: assessment and clinical importance. 
Triangle 1966; 7:240-3.
17. Colli AS, Berquió ES, Marques RM. Crescimento e desenvolvimento 
pubertário em crianças e adolescentes brasileiros. Volume testicular. 
In: Colli AS, Berquió ES, Marques RM. São Paulo: Brasileira de 
Ciências, 1984, pp. 1-34.
18. Atkinson GO, Patrick LE, Ball TI. The normal and abnormal 
scrotum in children: evaluation with color Doppler sonography. Am 
J Roentgenol 1992; 158:613-7.
19. Turner HE, Wass JA. Gonadal function in men with chronic illness. 
Clin Endocrinol (Oxford) 1997; 47:379-403.
20. World Health Organization (WHO). Laboratory manual for the 
examination of human semen and sperm-cervical mucus interaction. 
4 ed. New York: Cambridge University Press, 1999, pp. 1-128.
21. Kruger TF, Acosta AA, Simmons KF, et al. Predictive value of 
abnormal sperm morphology in vitro fertilization. Fertil Steril 1988; 
49:112-7.
22. Isenberg DA, Allen E, Farewell V et al. International consensus 
outcome measures for patients with idiopathic inflammatory 
myopathies. Development and initial validation of myositis 
activity and damage indices in patients with adult onset disease. 
Rheumatology (Oxford) 2004; 43:49-54.
23. Quaresma MR, Goldsmith CH, Lamont J, Ferraz MB. Assessment 
of sexual function in patients with rheumatic disorders: a critical 
appraisal. J Rheumatol 1997; 24:1673-6.
24. Helland Y, Dagfinrud H, Kvien TK. Perceived influence of 
health status on sexual activity in RA patients: associations with 
demographic and disease-related variables. Scand J Rheumatol 2008; 
37:194-9.
25. Dincer U, Cakar E, Kiralp MZ, Dursun H. Assessment of sexual 
dysfunction in male patients with Ankylosing Spondylitis. Rheumatol 
Int 2007; 27:561-6.
26. Stein H, Walters K, Dillon A, Schulzer M. Systemic lupus 
erythematosus – a medical and social profile. J Rheumatol 1986; 
13:570-5.
27. Folomeev M, Alekberova Z. Impotence in systemic lupus 
erythematosus. J Rheumatol 1990; 17:117-9.
28. Pinheiro GR, Goldenberg J, Atra E, Pereira RB, Camano L, Schmidt 
B. Juvenile dermatomyositis and pregnancy: report and literature 
review. J Rheumatol 1992; 19:1798-801.
29. Silva CA, Leal MM, Febrônio MV et al. Gravidez em adolescentes 
com dermatomiosite juvenil (DMJ). Rev Bras Reumatol 2005; 
45:180-4.
30. Váncsa A, Ponyi A, Constantin T, Zeher M, Dankó K. Pregnancy 
outcome in idiopathic inflammatory myopathy. Rheumatol Int 2007; 
27:435-9.
31. Mulligan T, Reddy S, Gulur PV, Godschalk M. Disorders of male 
sexual function. Clin Geriatr Med 2003; 19:473-81.
32. Silva CA, Hilario MO, Febronio MV et al. Pregnancy outcome in 
juvenile systemic lupus erythematosus: a Brazilian multicenter cohort 
study. J Rheumatol 2008; 35:1414-8.
33. Febronio MV, Pereira RM, Bonfa E, Takiuti AD, Pereyra EA, Silva 
CA. Inflammatory cervicovaginal cytology is associated with disease 
activity in juvenile systemic lupus erythematosus. Lupus 2007; 
16:430-5.
34. de Vincentiis S, Febrônio MV, da Silva CA, Saito MI, Takiuti AD, 
Valente KD. Sexuality in teenagers with epilepsy. Epilepsy Behav 
2008; 13:703-6.
35. Silva CA, Leal MM, Leone C et al. Gonadal function in adolescents 
and young women with juvenile systemic lupus erythematosus. 
Lupus 2002; 11: 419-25.
